517 results on '"Stolk, Jan"'
Search Results
2. Unique Synergy for Low Velocity Impact Deformation Reduction in Dyneema®-Carbon Intraply-Interlayer Hybrid Composite Panel
3. WED-182 The enhanced liver fibrosis test in alpha-1 antitrypsin deficiency patients homozygous for the Z-allele
4. WED-135-YI Impact of metabolic alterations on liver phenotype of patients with homozygous alpha-1 antitrypsin deficiency (Pi*ZZ)
5. TOP-141 Longitudinal assessment of individuals with homozygous alpha-1 antitrypsin deficiency (Pi*ZZ genotype) provides evidence for clinical patient management
6. WED-179-YI Liver fibrosis status and circulating polymers in alpha-1 antitrypsin deficiency patients with a Z/rare genotype
7. Loss of Pulmonary Endothelial Cells in Emphysema Impairs Support of Human Alveolar Epithelial Cell Growth
8. Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
9. Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patients
10. Keratin 8 is a scaffolding and regulatory protein of ERAD complexes
11. A framework for pulmonary fissure segmentation in 3D CT images using a directional derivative of plate filter
12. Loss of Pulmonary Endothelial Cells in Emphysema Impairs Support of Human Alveolar Epithelial Cell Growth.
13. Early immune development in the human fetal lung
14. Treatment of emphysema in patients with very severe alpha-1-antitrypsin deficiency
15. Governmental Non-Pharmaceutical Interventions during the COVID-19 Pandemic and the COPD Exacerbation and Respiratory Infection Rate in Patients with Alpha-1 Antitrypsin Deficiency
16. Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation
17. Strategic positioning of carbon fiber layers in an UHMwPE ballistic hybrid composite panel
18. Registries: roles, objectives and registry data study outcomes
19. Pulmonary Vascular Morphology Associated With Gas Exchange in Systemic Sclerosis Without Lung Fibrosis
20. Fibrosis-Related Gene Profiling in Liver Biopsies of PiZZ α1-Antitrypsin Children with Different Clinical Courses
21. Unique Synergy for Low Velocity Impact Deformation Reduction in Dyneema®-Carbon Intraply-Interlayer Hybrid Composite Panel
22. Direct comparison of the compliance method with optical tracking of fatigue crack propagation in polymers
23. Lung structure and function relation in systemic sclerosis: Application of lung densitometry
24. A Strain Energy Filter for 3D Vessel Enhancement
25. Establishing European Registries for AATD and Clinical Trials for Lung Disease
26. List of Contributors
27. Lung Density and Pulmonary Artery Diameter are Predictors of Pulmonary Hypertension in Systemic Sclerosis
28. Organoid-based expansion of patient-derived primary alveolar type 2 cells for establishment of alveolus epithelial Lung-Chip cultures
29. Biomarker identification to assess effects of bone-marrow derived mesenchymal stromal cell-therapy in emphysema through immune profiling
30. The Relationship between Plasma Alpha-1-Antitrypsin Polymers and Lung or Liver Function in ZZ Alpha-1-Antitrypsin-Deficient Patients
31. Keratin 8 is a scaffolding and regulatory protein of ERAD complexes
32. Micellar Electrokinetic Chromatography with Laser Induced Detection and liquid chromatography tandem mass-spectrometry-based desmosine assays in urine of patients with Chronic Obstructive Pulmonary Disease: A comparative analysis
33. Recombinant SLPI: Emphysema and Asthma
34. A quantitative method for detection of spliced X-box binding protein-1 (XBP1) mRNA as a measure of endoplasmic reticulum (ER) stress
35. Influence of inspiration level on bronchial lumen measurements with computed tomography
36. A strain energy filter for 3D vessel enhancement with application to pulmonary CT images
37. Baseline characteristics of patients enrolled in the EARCO prospective registry of alpha-1 antitrypsin deficiency: preliminary results
38. Long-term effect of alpha-1-antitrypsin augmentation therapy on the decline of FEV1 in deficient patients
39. Effect of intravenous alpha-1-antitrypsin augmentation therapy on proteinase-3-generated AaVal541 in deficient patients
40. Late Breaking Abstract - Impact of COVID-19 on patients with severe alpha1 antitrypsin deficiency: the IMCA1 study of the EARCO ERS Clinical Research Collaboration, preliminary findings
41. Alpha-1 Antitrypsin Regulates Transcriptional Levels of Serine Proteases in Blood Mononuclear Cells
42. Impact of pulmonary fibrosis and elevated pulmonary pressures on right ventricular function in patients with systemic sclerosis
43. The Course of AαVal541 as a Proteinase 3 Specific Neo-Epitope after Alpha-1-Antitrypsin Augmentation in Severe Deficient Patients
44. Long-term effect of α1-antitrypsin augmentation therapy on the decline of FEV1 in deficient patients: an analysis of the AIR database
45. Polymerization of misfolded Z alpha-1 antitrypsin protein lowers CX3CR1 expression in human PBMCs
46. Relationship between Change in Lung Density and Long-Term Progression of Lung Function
47. Effectiveness of TNF inhibitor treatment with various methotrexate doses in patients with rheumatoid arthritis: results from clinical practice
48. Chemical, Biochemical, Pharmacokinetic, and Biological Properties of L-680, 833: A Potent, Orally Active Monocyclic β-Lactam Inhibitor of Human Polymorphonuclear Leukocyte Elastase
49. Author response: Polymerization of misfolded Z alpha-1 antitrypsin protein lowers CX3CR1 expression in human PBMCs
50. Assessment of Regional Progression of Pulmonary Emphysema With CT Densitometry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.